The Impact of Disopyramide on Exercise Capacity Among Patients with Obstructive Hypertrophic Cardiomyopathy: Beyond LVOT Gradient
Eur J Prev Cardiol
.
2024 Jun 8:zwae198.
doi: 10.1093/eurjpc/zwae198.
Online ahead of print.
Authors
Geza Halasz
1
,
Lorenzo Lupo Dei
2
,
Francesco Moroni
3
,
Michael P Ayers
3
,
Paolo Ciacci
4
,
Guido Giacalone
5
,
Raffaella Mistrulli
6
,
Marco Redivo
5
,
Santiago Orellana
5
,
Domenico Gabrielli
1
,
Massimo Piepoli
7
,
Federica Re
1
Affiliations
1
Division of Cardiology, Cardio-Thoracic and Vascular Department, Azienda Ospedaliera San Camillo Forlanini, Rome, ITALY.
2
University of L'Aquila, Department of Clinical Medicine, Public Health, Life and Environmental Science, L'aquila, Italy.
3
Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, Virginia, USA.
4
Campus Bio-Medico University Of Rome, Rome, Italy.
5
Division of Cardiology, Azienda ospedaliera universitaria Sant'Andrea, Rome, ITALY.
6
Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.
7
Department of Biomedical Science for Health, University of Milan, Milan, Italy.
PMID:
38850169
DOI:
10.1093/eurjpc/zwae198
No abstract available
Keywords:
Disopyramide; Exercise capacity; Obstructive Hypertrophic Cardiomyopathy.